During the past decade, Kinderspital Zürich conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 9 clinical trials were completed, i.e. on average, 26.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kinderspital Zürich" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 8 trials, followed by "AO Clinical Investigation and Publishing Documentation" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Celgene" with 2 trials sponsored and "Eisai Inc." with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kinderspital Zürich" #1 collaborator was "ALL SCTped Forum" with 2 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Luzerner Kantonsspital" with 2 trials as a collaborator, "ALL-BFM Study Group" with 1 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "Kinderspital Zürich" are "Cystic Fibrosis" (8 trials), "Neuroblastoma" (2 trials), "Rhabdomyosarcoma" (2 trials), "Venous Thromboembolism" (2 trials) and "AB Variant Gangliosidosis GM2" (1 trials). Many other conditions were trialed in "Kinderspital Zürich" in a lesser frequency.

Most popular intervention types in "Kinderspital Zürich" are "Drug" (26 trials), "Other" (6 trials), "Device" (3 trials), "Genetic" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "IVA" (8 trials), "ELX/TEZ/IVA" (5 trials), "Cyclophosphamide" (3 trials), "Ifosfamide" (3 trials) and "Placebo (matched to ELX/TEZ/IVA)" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kinderspital Zürich" are 42 trials for "All" genders.

Currently, there are 22 active trials in "Kinderspital Zürich". 1 are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Kinderspital Zürich, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kinderspital Zürich, 4 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".